Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;31(2):54-58.
doi: 10.1297/cpe.2021-0059. Epub 2021 Dec 16.

Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors

Affiliations

Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors

Shunsuke Shimazaki et al. Clin Pediatr Endocrinol. 2022.

Abstract

Thyroid dysfunction has been observed in childhood cancer survivors (CCSs) who have undergone hematopoietic stem cell transplantation (HSCT). We retrospectively analyzed the thyroid function of 54 CCSs who underwent HSCT and were referred to our endocrinology department at Chiba Children's Hospital between January 1, 2008, and December 31, 2019. Three patients developed autoimmune thyroid disease (AITD) after HSCT. Two of these patients had Graves' disease (GD), and the third had autoimmune thyroiditis. The association between HSCT and AITD remains unclear. All three patients had chronic graft versus host disease (GVHD). AITD was reported to be induced by the transmission of abnormal T or B lymphocyte clones from the donor to the recipient. One patient with GD was treated with a high dose of anti-thymocyte globulin (ATG). Some studies have reported that ATG is associated with a risk of severe T cell depletion and GD onset. In conclusion, CCSs who received HSCT rarely developed AITD. We suggest that CCSs treated with ATG and/or experiencing an onset of chronic GVHD should be carefully monitored for thyroid function because it might reveal AITD.

Keywords: Graves’ disease; autoimmune thyroid disease; autoimmune thyroiditis; childhood cancer survivors; hematopoietic stem cell transplantation.

PubMed Disclaimer

Conflict of interest statement

None of the authors reports financial relationships relevant to this article.

Similar articles

Cited by

References

    1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. . Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010;363: 2091–101. doi: 10.1056/NEJMoa1004383 - DOI - PMC - PubMed
    1. Matsumoto M, Ishiguro H, Tomita Y, Inoue H, Yasuda Y, Shimizu T, et al. . Changes in thyroid function after bone marrow transplant in young patients. Pediatr Int 2004;46: 291–5. doi: 10.1111/j.1442-200x.2004.01894.x - DOI - PubMed
    1. Au WY, Lie AKW, Kung AWC, Liang R, Hawkins BR, Kwong YL. Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;35: 383–8. doi: 10.1038/sj.bmt.1704766 - DOI - PubMed
    1. Iwaku K, Noh JY, Minagawa A, Kosuga Y, Suzuki M, Sekiya K, et al. . Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kits. Endocr J 2013;60: 799–804. doi: 10.1507/endocrj.EJ12-0390 - DOI - PubMed
    1. Suzuki S, Midorikawa S, Fukushima T, Shimura H, Ohira T, Ohtsuru A, et al. . Thyroid Examination Unit of the Radiation Medical Science Center for the Fukushima Health Management Survey. Systematic determination of thyroid volume by ultrasound examination from infancy to adolescence in Japan: the Fukushima Health Management Survey. Endocr J 2015;62: 261–8. doi: 10.1507/endocrj.EJ14-0478 - DOI - PubMed